← Insider buys
CHRS

Coherus Oncology, Inc. · Healthcare

Director Mats Wahlstrom sold $1.5M of Coherus Oncology, Inc.

Sold$1,474,677
$27.52Price
53,583Shares
−8%Stake

What CHRS did after the filing

Prices for CHRS after this filing aren't in yet.

Traded Wed, Dec 7. Filed Fri, Dec 9, 11:05 AM ET, during the session. Not investment advice.